Cele Abad‐Zapatero

Author

Cele Abad‐Zapatero

Abbott Fund

Also Known As

Abad-Zapatero, Cele, C ABADZAPATERO, CELE ABAD-ZAPATERO, Cele Abad-Zapatero, Cele Abad‐Zapatero

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United States)University of Illinois Chicago Abbott (United Kingdom)Ashland (United States)

About

Cele Abad‐Zapatero is an author at Abbott Fund specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	1.9K
2	Biochemistry	20	23	1.9K
3	Natural Sciences	19	21	1.7K
4	Cell Biology	2	2	218
5	Engineering	1	1	93

Cele Abad‐Zapatero

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Ligand efficiency indices for effective drug discovery Cele Abad‐Zapatero Expert Opinion on Drug Discovery Molecular DockingMedicinal ChemistryEffective Drug DiscoveryHit IdentificationBiochemistry	2007	270
Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy Bruce G. Szczepankiewicz, Gang Liu, Philip J. Hajduk, Journal of the American Chemical Society Type Ii DiabetesDrug TargetBiochemistryNatural SciencesMedicine	2003	226
Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B Inhibitor Gang Liu, Zhili Xin, Zhonghua Pei, Journal of Medicinal Chemistry Drug TargetProtein AssemblyMolecular BiologyReceptor Tyrosine KinaseProtein X-ray Crystallography	2003	160
Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity Bruce G. Szczepankiewicz, Christi Kosogof, Lissa T.J. Nelson, Journal of Medicinal Chemistry Little Inhibitory ActivityDrug TargetPharmacotherapyChemical BiologyDrug Resistance	2006	159
Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain Cele Abad‐Zapatero, T.J. Rydel, John W. Erickson Proteins Structure Function and Bioinformatics	1990	120
Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation Cele Abad‐Zapatero, Ognjen Perišić, John Wass, Drug Discovery Today Molecular RecognitionAtlas-like RepresentationSystems BiologyMolecular DiversityBiochemistry	2010	116
Structure of a secreted aspartic protease from <i>C. albicans</i> complexed with a potent inhibitor: Implications for the design of antifungal agents Cele Abad‐Zapatero, Robert C. Goldman, Steven W. Muchmore, Protein Science	1996	113
Crystal Structure of ErmC‘, an rRNA Methyltransferase Which Mediates Antibiotic Resistance in Bacteria Dirksen E. Bussiere, Steven W. Muchmore, Christopher G. Dealwis, Biochemistry Crystal StructureErmc ‘Antimicrobial Resistance GeneBiomolecular Structure PredictionBacteriology	1998	109
The 2.2 Å structure of the rRNA methyltransferase ErmC′ and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism Gerd Schluckebier, Ping Zhong, Kent D. Stewart, Journal of Molecular Biology å StructureNucleic Acid ChemistryBiochemistryRrna Methyltransferase Ermc′Natural Sciences	1999	108
Selective Protein Tyrosine Phosphatase 1B Inhibitors: Targeting the Second Phosphotyrosine Binding Site with Non-Carboxylic Acid-Containing Ligands Gang Liu, Zhili Xin, Heng Liang, Journal of Medicinal Chemistry Drug TargetChemical BiologyReceptor Tyrosine KinasePotent Ptp1b InhibitorsCell Signaling	2003	106

Page 1